Related Experiment Video
Updated: Jun 14, 2026
09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
Chronic cerebrospinal venous insufficiency and multiple sclerosis.
Omar Khan1, Massimo Filippi, Mark S Freedman
1Multiple Sclerosis Center, Department of Neurology, Wayne State University School of Medicine, 4201 St Antoine, Detroit, MI 48323, USA. okhan@med.wayne.edu
Annals of Neurology
|April 8, 2010
Summary
Chronic cerebrospinal venous insufficiency (CCSVI) is a debated condition linked to multiple sclerosis (MS). Current evidence and invasive treatments are insufficient, necessitating rigorous research before widespread adoption.
Area of Science:
- Neurology
- Vascular Medicine
- Immunology
Background:
- Chronic cerebrospinal venous insufficiency (CCSVI) is proposed as a pathological condition exclusively associated with multiple sclerosis (MS).
- This hypothesis has spurred significant interest in the potential causal link between CCSVI and MS, influencing treatment discussions.
- Proposed treatments include endovascular procedures like balloon angioplasty or venous stenting, which have been performed in small patient series with some reports of serious injury.
Purpose of the Study:
- To critically evaluate the scientific investigations supporting the link between CCSVI and MS.
- To discuss the conceptual and technical limitations of current research on CCSVI.
- To address the safety and efficacy concerns regarding endovascular treatments for MS.
Main Methods:
- Review of recent scientific literature and investigations on CCSVI.
- Analysis of conceptual and methodological shortcomings in studies linking CCSVI to MS.
- Discussion of clinical observations and potential risks associated with endovascular interventions.
Main Results:
- The relationship between CCSVI and MS remains inadequately established due to conceptual and technical limitations in existing research.
- Concerns exist regarding the safety and potential for serious injury from invasive endovascular procedures.
- Scientific bodies acknowledge the need for well-designed, controlled studies to investigate CCSVI in MS.
Conclusions:
- The current evidence does not robustly support CCSVI as a cause or consistent finding in MS.
- Invasive endovascular treatments for MS, based on the CCSVI hypothesis, should be discouraged pending further rigorous scientific investigation.
- Carefully designed, controlled studies are essential to definitively ascertain the role, if any, of CCSVI in MS and to evaluate potential therapeutic interventions.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:29Increased Intracranial Pressure ll: Pathophysiology
Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
01:14Increased Intracranial Pressure l: Introduction
Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
01:19Veins of Head and Neck
The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...